Abstract Musculoskeletal pathologies pose significant challenges in athletic horses, often leading to loss of function. The limited healing capacity of bone, joint, and tendon/ligament injuries, combined with the inefficacy of conventional treatments, underscores the need for innovative therapeutic strategies such as Mesenchymal Stem/Stroma Cells (MSCs). Conventional cell culture methods typically employ two-dimensional (2D) culture systems with adherent cells using fetal bovine serum. However, three-dimensional (3D) cell culture offers a more physiologically relevant milieu, closely resembling native tissue architecture and in vivo cell-cell interactions. This study introduces a novel approach for isolating muscle-derived progenitor cells in a 3D environment, utilizing an autologous plasma-based gel and an innovative cell retrieval solution. The muscle-derived progenitor cells cultured using this method exhibited immunomodulatory properties on lymphocyte T and trilineage differentiation and immunophenotyping akin to traditional MSCs. This simplified 3D culture technique holds promise for generating minimally manipulated autologous cell products tailored for musculoskeletal applications.
No takes yet. Share an insight, caveat, or question.
Graide et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: